
Academic Journal
Q4NeuroSignals
About NeuroSignals
About NeuroSignals
NeuroSignals is a peer-reviewed scholarly journal published by Cell Physiol Biochem Press GmbH & Co KG (Switzerland). It focuses on Q4. Publication coverage spans 1992-2016, 2018-2022, 2024-2025.
Key indicators: ISSN 1424-8638, 1424-862X; H-index 75.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (75): Strong citation impact — 75 articles cited at least 75 times each, reflecting solid influence.
Publishing in NeuroSignals
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q4. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of NeuroSignals?
1424-8638, 1424-862X.
Who publishes NeuroSignals?
Cell Physiol Biochem Press GmbH & Co KG.
What are NeuroSignals's metrics?
H-index 75.
Is NeuroSignals peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-08-04. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
- Copyright policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Diverse Scientific and Economic Studies; Human auditory perception and evaluation; Circadian rhythm and melatonin; Neuroscience and Neuropharmacology Research; Receptor Mechanisms and Signaling; Legal Cases and Commentary.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis
Noel Pabalan, Sarawut Lapmanee, Phuntila Tharabenjasin, Panan Suntornsaratoo et al.
2026-04-17 · DOI: 10.33594/000000861The Impact of Vitamin D Deficiency on Cognitive and Neuromuscular Functions in Elderly Patients
Mohamed Ghalib Zakari, Bassam Taha Saleh, Abdulsattar Hussein Abdullah
2025-12-17 · DOI: 10.33594/000000836Tracing the Evolution and Recombination Events of Neurotropic Arenaviridae Viruses: a Bioinformatics Approach
Meaad Hussein Al-Abadi, Bashar Talib Hameed Al-nuaimi
2025-09-30 · DOI: 10.33594/000000817Peripheral Inflammation as a Biomarker of Disease Activity in Relapsing-Remitting MS
Abdulsattar Hussein Abdullaha
2025-09-14 · DOI: 10.33594/000000814Aberrant Hippocampal Neuroregenerative Plasticity in Schizophrenia: Reactive Neuroblastosis as a Possible Pathocellular Mechanism of Hallucination
2024-07-04 · DOI: 10.33594/000000712A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma
2022-11-11 · DOI: 10.33594/000000585Therapy Resistance and Failure in Uveal Melanoma
2022-08-10 · DOI: 10.33594/000000555Interventional Radiotherapy (Brachytherapy) in Eyelid and Ocular Surface Tumors: A Review for Treatment of Naïve and Recurrent Malignancies
2022-03-25 · DOI: 10.33594/000000505Increase of Kynurenic Acid after Encephalomyocarditis Virus Infection and Its Significances
2021-09-30 · DOI: 10.33594/000000434Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab
2021-05-05 · DOI: 10.33594/000000367Klotho-Dependent Role of 1,25(OH)2D3 in the Brain
2021-03-31 · DOI: 10.33594/000000352Intervention of Tyrosine Hydroxylase Expression Alters Joint Inflammation and Th17/Treg Imbalance in Collagen-Induced Arthritis
2021-02-06 · DOI: 10.33594/000000328The Putative Role of 1,25(OH)2D3 in the Association of Milk Consumption and Parkinson’s Disease
2020-12-31 · DOI: 10.33594/000000321Kynurenine Aminotransferases I, II and III Are Present in Saliva.
2020-03-11 · DOI: 10.33594/000000217Sphingomyelin Synthases in Neuropsychiatric Health and Disease
2019-12-27 · DOI: 10.33594/000000200Interferon in the CNS
2019-12-23 · DOI: 10.33594/000000197When the Brain Yearns for Oxygen
2019-12-21 · DOI: 10.33594/000000199The Acid Sphingomyelinase/ Ceramide System as Target for Ischemic Stroke Therapies
2019-11-29 · DOI: 10.33594/000000184Pharmacological Inhibition of Acid Sphingomyelinase Ameliorates Experimental Autoimmune Encephalomyelitis
2019-11-29 · DOI: 10.33594/0000001831,25(OH)2D3 in Brain Function and Neuropsychiatric Disease
2019-11-23 · DOI: 10.33594/000000182Reviews
Community Reviews
Version History
October 10, 2026 at 1:15 pm
October 2, 2026